Alpha Biopharma Announces Series A Financing

SHANGHAI, June 19, 2018 -- (Healthcare Sales & Marketing Network) -- Alpha Biopharma Inc. ("AlphaBio") today announced the first $37M closing of its $65M Series A financing led by Qiming Venture Partners, one of the most prominent venture capita... Biopharmaceuticals, Oncology, Venture Capital, Personnel Alpha Biopharma, NSCLC, tyrosine kinase inhibitor
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news